growth characteristics in vivo as well as radiation response in vitro may be of prognostic value for prediction of radioresponsiveness of melanomas.
Clinical studies have shown that some histological types of human tumours are more radioresistant than others (Rubin et al., 1974) . However, histology is probably not a major determinant of radioresponsiveness since different tumours of the same histological type may require totally different doses to be locally controlled (Thames et al., 1980; . Several tumour parameters, e.g. the number of clonogenic cells, the fraction of hypoxic cells, the efficiency of reoxygenation, the intrinsic cellular radiosensitivity and the capacity for repair of sublethal and potentially lethal damage, may affect the radioresponsiveness of tumours. Thus, in attempts to improve the efficacy of radiotherapy, it would appear relevant to try to identify the major cause of radioresistance of any given tumour population. The major cause of radioresistance is not necessarily the same in different tumour populations, not even for tumours of equal radiocurability. In some tumour populations, several biological factors may contribute about equally to the radioresistance, and hence no major cause of radioresistance exists (Fowler, 1974; .
Since human tumours can be grown successfully in congenitally athymic mice and immuneCorrespondence: E.K. Rofstad Received 3 July 1984: and in revised form 25 October 1984. suppressed mice, human tumour xenografts may be used to identify causes of radioresistance in different tumour populations (Rofstad, 1982) . Studies of growth delay caused by single dose irradiation have shown that the radiation response varies considerably among xenografts of different histological types, and there is some evidence that the radiation response correlates with the clinical responsiveness of tumours of corresponding histology (Steel, 1984) . However, so far no studies on the variability in radiation response in vivo among xenografts of the same histological type have been reported.
Biological characteristics of human melanoma xenografts are currently studied at our institute. The studies have been concentrated on 5 different lines of xenografts of similar histology, which originated from tumours in 5 different patients. These xenograft tumour lines show individuality with respect to: characteristic growth patterns ; vascular structures (Solesvik et al., 1982) ; and, X-ray survival curves following irradiation in vitro (Rofstad & Brustad, 1981 Five different human melanomas (E.E., E.F., G.E., M.F., V.N.), which each were derived from metastases of patients at The Norwegian Radium Hospital, were studied in the present work. The melanomas were transplanted directly into athymic mice without previous adaptation to in vitro culture conditions. Histologically all of the 5 parent metastases were similar. Both cells and nuclei varied greatly in size and shape.
The melanomas were grown serially in athymic mice by implanting fragments, 2 x 2 x 2mm in size, s.c. into the flanks of recipient mice. Passages 20-52 in athymic mice were used in the present study. The melanomas were kinetically stable during the period the experiments were carried out, as ascertained by flow cytometric measurements of DNA histograms and measurements of volumetric growth rates . Light and electron microscopic examinations showed that the histological appearance of the xenografts was similar to that of the metastases in the donor patients.
Irradiation and assay in vivo Non-anaesthetized, air-breathing mice were irradiated locally at a dose rate of 5.1 Gy min -by using a "Stabilipan" X-ray unit, operated at 220 kV and 20 mA, with 0.5 mm Cu filtration. A 15 x 15mm hole through a 2 cm thick lead block served as beam-defining aperture. During exposure the mice were kept in specially made, thin-walled Perspex tubes with a hole in the cranial end through which they could breathe freely. A piston in the tail end positioned the mice firmly in the tubes. A hole was cut in each tube through which the tumours protruded. The tumour volumes at the time of irradiation were 200-500mm3. To ensure uniform doses throughout the tumour volumes, tumours were exposed to irradiations by two opposing treatment fields through each of which 50% of the total dose was delivered.
The tumour volumes before and after irradiation were measured with calipers. Two perpendicular diameters (length and width) were recorded and the tumour volumes were calculated as V= 1/2 ab2 where a and b are the longest and the shortest diameter, respectively. Since the skin around the tumours was thin, the measured tumour diameters were not corrected for the skin thickness.
The time taken for the irradiated (T'2) and the control tumours (T2) to double their volume as measured immediately before irradiation was recorded. Actual tumour growth delay was calculated as T'2-T2 and specific growth delay as:
T12-T2 T2
Specific growth delay may be regarded as an estimate of the number of volume-doubling times the growth is delayed after a given dose. This parameter allows comparisons to be made between the radiation response of tumours having different growth rates prior to irradiation (Hermens & Barendsen, 1975; Nowak et al., 1978; Steel et al., 1983) .
Irradiation and assay in vitro First, single cell suspensions were prepared from the melanomas and subsequently these were irradiated under aerobic conditions and the colony forming ability of the cells was assayed in soft agar (Courtenay & Mills, 1978) as reported previously (Rofstad & Brustad, 1981) .
Biological characteristics Biological characteristics of the melanomas have also been reported previously: Growth fraction and cell loss factor were calculated from PLM-curves, labelling index data and growth curves (Rofstad et al., 1977 (Rofstad et al., , 1980 (Rofstad et al., , 1982 Rofstad, 1984) . Fraction of cells in S-phase and DNA-index were calculated from DNA-histograms obtained by flow cytometry (Lindmo & Steen, 1977; Rofstad et al., 1982) . Vascular parameters were determined by stereological analysis of histological sections from tumours whose vascular system was filled with a contrast medium (Solesvik et al., 1982) . Results and discussion Variability in radiation response Growth curves for irradiated and unirradiated tumours are presented in Figure 1 . Statistical analysis showed that the response to a given dose was independent of the pretr'eatment tumour volume, which ranged from 200 to 500mm3. Thus Figure 3 where specific growth delay is shown as a function of radiation dose. Steel (1984) concluded that his data give some support for the assumption that the radiation response of xenografts correlates with the clinical responsiveness of tumours of corresponding histology. The small-cell bronchial carcinoma and the testicular teratoma xenografts
Dose (Gy) Figure 3 Specific growth delay as a function of radiation dose for human tumour xenografts. Testicular teratoma (1), pancreatic carcinoma (2), small-cell bronchial carcinoma (3), bladder carcinoma (4) and bronchial adenocarcinoma (5) (Steel, 1984) . The hatched area represents the range of specific growth delays for 5 melanomas (from Figure 2b) . were relatively radiosensitive and these tumour types are known to be radiosensitive clinically. The bronchial adenocarcinoma and the bladder carcinoma xenografts on the other hand were found to be radioresistant as these tumour types often are clinically. The hatched area in Figure 3 shows the range of specific growth delays for the melanoma xenografts, derived from Figure 2b . The two most radioresistant melanomas showed about the same specific growth delays as the bladder carcinoma and the bronchial adenocarcinoma, whereas the specific growth delays for the two most radiosensitive melanomas were similar to those for the small-cell bronchial carcinoma. Figure 3 Figure 4 shows specific growth delay after 15 Gy as a function of volume-doubling time (T2). The melanomas having short volume-doubling times were more radiosensitive than those having long volume-doubling times.
Previous studies have shown that the rapidly growing melanomas have higher growth fractions and lower cell loss factors than the slowly growing ones . Figure 5 shows specific growth delay after 15 Gy as a function of growth fraction and cell loss factor. The figure indicates that specific growth delay tended to increase with increasing growth fraction which was also concluded by Hermens & Barendsen (1975) , and to decrease with increasing cell loss factor.
It has also been shown that the vascular volume is larger for the rapidly than for the slowly growing melanomas (Rofstad, 1984) . Specific growth delay after 15 Gy is shown as a function of vascular density in Figure 6 . Four different vascular parameters were considered; capillary length, i.e. length of vessels with diameters in the range 5- . Since the radiosensitivity of cells depends on their position in the cell-cycle and since DNA is a primary target for the action of ionizing radiation, it is interesting to attempt to relate the radioresponsiveness of the melanomas to the fraction of cells in S-phase and the DNA-index. However, Figure 7 shows that specific growth delay after 15 Gy did not decrease with increasing value of any of these two flow cytometric parameters, as would be expected if these parameters were of major importance for the radioresponsiveness of the melanomas.
In conclusion, the most radioresistant melanomas have the longest volume-doubling time, the lowest growth fraction, the highest cell loss factor and the lowest vascular density. There is also some evidence from clinical studies that the radiation response of tumours may be related to the pretreatment rate of growth. Tubiana et al. (1975) Cell loss factor radiotherapy than rapidly growing ones. Also Breur (1966) , who studied the radiation response of lung metastases, observed that tumour shrinkage increased with increasing rate of pretreatment growth. However, even if there is a correlation between radioresponsiveness and tumour growth, the present study indicates that it may be difficult to predict radioresponsiveness from flow cytometric measurements of DNA histograms.
Specific growth delay vs cellular radiosensitivity
Also the radiation response in vitro varied significantly among the melanomas. Survival curves for cells irradiated in suspension under aerobic conditions are presented in Figure 8 . The question then arises whether the radiation response in vivo is related to the cellular radiosensitivity as measured in vitro. Specific growth delay after 15 Gy is shown as a function of surviving fraction in vitro after 6Gy in Figure 9a . Six Gy was the highest dose common for the melanomas under in vitro conditions, and the surviving fractions after this dose were in the same range as those measured in vitro following exposure to 15 Gy in vivo Flaten et al., 1981) . Figure 9a shows that specific growth delay in vivo increased with decreasing surviving fraction in vitro. If it is assumed that the differences in cell survival measured at 6Gy among the melanomas are also valid after exposure to 15 Gy in vivo, this observation suggests that the radioresponsiveness in vivo is correlated to the cellular radiosensitivity in vitro. However, specific growth delay after 15 Gy did not appear to correlate to the Do value of the in vitro survival curves (Figure 9b ). The observation that the specific growth delay after 15 Gy was correlated to the surviving fraction after 6 Gy, but not clearly to the Do value, is due to the large difference in shoulder-width among the in vitro survival curves.
The present finding is in agreement with the suggestions of Barendsen (1980 Barendsen ( , 1983 and Fertil & Malaise (1981) that the cellular radiosensitivity is among the main factors which are decisive for the radioresponsiveness of tumours. Barendsen found that in vitro survival curves might vary considerably among cell lines established from different mouse and rat tumours, and showed theoretically that this variability would imply large differences in radiocurability of the corresponding tumours. Fertil & Malaise reviewed published survival curves for cell lines established from human tumours and showed that the survival level after 2Gy, but not that after 8 Gy, was positively correlated to the radioresponsiveness of tumours of corresponding histological type.
Conclusion
In conclusion, the radiation response in vivo E.E. varied considerably among melanoma xenografts derived from different patients. If the present data are representative for melanomas in man, they suggest that certain tumour growth parameters as well as given dose-survival factors in vitro may be of value for prognostication of the radioresponsiveness of individual melanomas.
